The cost of treating a type 2 diabetes patient throughout their lifetime is estimated to be $85,500….
Read More »Higher Heart Risk Seen with Diabetes Plus ESRD
Diabetes and end stage renal disease (ESRD), when together, contribute to increased cardiovascular (CV) events, such as acute myocardial infarction and stroke….
Read More »Diabetes and Cardiovascular Risk in Metabolically Healthy Obese Individuals
Do metabolically healthy obese individuals have higher risks for diabetes and CVD?…
Read More »Diet and Kidney Disease in High-Risk Individuals with Type 2 Diabetes
How does diet, alcohol consumption, and sodium intake affect incidence or progression of CKD in diabetic patients?…
Read More »Prescription Coverage for SGLT2 inhibitors
Here’s out most recent list of insurance covereage. The cash price for 1 month of Invokana is $315.72. Current actual coverage is: RXE United and other discount cards are approximately $268. PSN Commercial calls it non-formulary and charges a $100 co-pay. AARP-United Health will allow the first fill with a $95 …
Read More »The Patient Perspective: Canagliflozin
We hear a lot from clinicians about new drugs but we don’t always get the patient perspective until much later. Invokana (canagliflozin) has been available for several months now, though, so we spoke with a few patients to find out what their experience has been so far: "I was on …
Read More »Risk of Early Heart Death for Offspring of Obese Moms
Analysis of data from nearly 30,000 women and 40,000 offspring showed that, individuals born to obese mothers have an increased risk for premature all-cause and cardiovascular death as adults….
Read More »Insulin, GLP-1 Combination Therapy Results
A new combination of long-acting insulin plus a GLP-1 compound is in phase 3 trials and the results are outstanding….
Read More »Metformin Boosts Survival in Men with Diabetes, Prostate Cancer
The longer patients were treated with metformin after being diagnosed with prostate cancer, the greater their survival rates were, depending on the dose they were given….
Read More »The Effect of Whole Grain Foods on Diabetes and Obesity
Researchers assessed the impact of whole grains on the risk of type 2 diabetes, obesity and body weight measures, and cardiovascular disease in human studies as the basis for establishing an American Society for Nutrition (ASN) position….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.